April 19, 2011 – A new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy has been introduced. The Capri applicator, from Varian Medical Systems, is aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose. It was exhibited recently at the annual American Brachytherapy Society (ABS) meeting in San Diego.

The applicator can also be used for treatment of vaginal and rectal cancers.

The device is a lightweight balloon applicator that is inflated upon insertion to adapt to each patient's anatomy and hold it in place during treatment. Prior to the applicator's development, the principle brachytherapy option for endometrial cancer patients involved inserting rigid cylinders, which may require the fixation of the applicator to the treatment table. It is also compatible with CT imaging, which enables doctors to use it with 3-D imaging to plan their treatments and determine exactly where they want to deposit the dose.

"We believe this applicator is a breakthrough for gynaecological treatments and will make a huge difference in treating post-hysterectomy endometrial cancer patients," said Ted Jackson, Ph.D., Varian BrachyTherapy's director of product development and engineering. "Our design is aimed at enhancing patient comfort and improving ease of use and we believe it has the potential to reduce the radiation dose to surrounding healthy tissues."

The Capri applicator has FDA clearance for gynaecological and rectal treatments in the United States and is awaiting CE approval for sale in Europe.

Rakesh Patel, the medical director of the Targeted Radiation Institute at Western Radiation Oncology (WRO) in Mountain View, Calif., said the Capri applicator supports 3-D treatment planning capabilities for high-dose rate (HDR) vaginal brachytherapy.

"We expect that the result will be to significantly improve dose distribution by allowing us to reduce the exposure of the rectum and bladder," he said. "This feature combined with its design aimed at improving ease of use and patient comfort enhances the current methods for this type of treatment. From our clinical observations, the patients tolerate the treatment very well."

Brachytherapy involves treating cancer by temporarily placing radioactive sources within or adjacent to tumors. About half of all U.S. endometrial cancer patients receive HDR brachytherapy as the standard of care post-hysterectomy. Endometrial cancer is the most common gynaecological cancer and the majority of women require a hysterectomy as part of their treatment.

For more information: www.varian.com


Related Content

News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now